NASDAQ:DCPH
Delisted

Deciphera Pharmaceuticals Stock News

etoro logo Buy DCPH
*Your capital is at risk
$25.59
+0 (+0%)
At Close: Sep 09, 2024
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) traded up 5.6% during mid-day trading on Friday . The stock traded as high as $48.45 and last traded at $48.02, 392,227 shares changed hands during mid-day
Deciphera Pharmaceuticals (DCPH) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Deciphera Pharmaceuticals (DCPH) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Director Michael Douglas Taylor sold 23,892 shares of the business’s stock in a transaction on Friday, April 17th. The shares were sold at an average pric

Is Deciphera Pharmaceuticals a Buy?

11:50am, Wednesday, 22'nd Apr 2020
What should investors think of this late-stage cancer biotech?
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) Director Michael Douglas Taylor sold 1,108 shares of the business’s stock in a transaction dated Tuesday, April 14th. The shares were sold at an average p
Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) was the recipient of a large growth in short interest in the month of March. As of March 31st, there was short interest totalling 3,060,000 shares, a growth
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE